Alternate-day administrations of S-1

2 trials

Sponsors

Pancreatic Cancer Treatment Research Group

Conditions

Metastatic or locally advanced pancreatic cancerMetastatic or locally advanced pancreatic cancer

Phase 2

Phase II study of alternate-day administrations of S-1 as 1st-line treatment in patients with metastatic and locally advanced pancreatic cancer

Active, not recruitingJPRN-UMIN000003453

Pancreatic Cancer Treatment Research GroupMetastatic or locally advanced pancreatic cancer

Start: 2009-08-01Target: 45Updated: 2026-06-29

Phase II study of alternate-day administrations of S-1 as 2nd-line treatment in patients with metastatic and locally advanced pancreatic cancer

Active, not recruitingJPRN-UMIN000003454

Pancreatic Cancer Treatment Research GroupMetastatic or locally advanced pancreatic cancer

Start: 2009-08-01Target: 45Updated: 2026-06-29